Overcoming Downstream Challenges in the Reduction of Key Process- & Product-related Impurities of an Antibody Drug Conjugate (ADC)

Time: 12:00 pm
day: day 1 track 4 am

Details:

• Identify critical and difficult to
remove impurities
• Evaluate development strategies
and results
• Discuss transfer, scale-up, and
GMP manufacturing results